Kwon Junki, Heo Jeong Hwa, Kim Hyo Myung, Song Jong Suk
Department of Ophthalmology, Korea University College of Medicine, Seoul, Korea.
Korean J Ophthalmol. 2015 Oct;29(5):344-50. doi: 10.3341/kjo.2015.29.5.344. Epub 2015 Sep 22.
To evaluate and compare the toxic effects of eyedrops containing a fixed combination of 2.0% dorzolamide and 0.5% maleate timolol with or without preservatives on rabbit corneal endothelium.
This study was performed with 22 eyes of New Zealand white rabbits. Dorzolamide/timolol eyedrops with preservative (Cosopt group) or without preservative (Cosopt-S group) were diluted with a balanced salt solution at a 1 : 1 ratio. We injected 0.1 mL of diluted Cosopt into the anterior chamber of left eyes and an equal volume of diluted Cosopt-S into the anterior chamber of right eyes. Corneal thickness, corneal haze, and conjunctival injection were measured before and 24 hours after treatment. Endothelial damage was compared between both eyes by vital staining (alizarin red/trypan blue staining), live/dead cell assay, TUNEL assay, and scanning electron microscopy.
Corneal endothelial damage was severe in the Cosopt group. Cosopt-treated eyes exhibited remarkable corneal edema and prominent apoptosis of endothelial cells. In addition, the live/dead cell assay revealed many dead cells in the endothelium, and scanning electron microscopy analysis showed that corneal endothelial cells exhibited a partial loss of microvilli on the surface as well as extensive destruction of intercellular junctions. However, in the Cosopt-S group, corneal edema was mild and the damage to the corneal endothelium was minimal.
The main cause of corneal endothelial toxicity was due to the preservative in the dorzolamide/timolol fixed combination eyedrops, and not the active ingredient. Thus, it appears to be safer to use preservative-free eyedrops during the early postoperative period.
评估和比较含2.0%多佐胺和0.5%噻吗洛尔马来酸盐固定组合且有或无防腐剂的滴眼液对兔角膜内皮的毒性作用。
本研究使用22只新西兰白兔的眼睛。含防腐剂的多佐胺/噻吗洛尔滴眼液(Cosopt组)或不含防腐剂的多佐胺/噻吗洛尔滴眼液(Cosopt-S组)用平衡盐溶液按1:1比例稀释。我们将0.1 mL稀释后的Cosopt注入左眼前房,将等体积的稀释后的Cosopt-S注入右眼前房。在治疗前和治疗后24小时测量角膜厚度、角膜混浊和结膜充血。通过活体染色(茜素红/台盼蓝染色)、活/死细胞检测、TUNEL检测和扫描电子显微镜比较双眼的内皮损伤情况。
Cosopt组角膜内皮损伤严重。Cosopt治疗的眼睛出现明显的角膜水肿和内皮细胞显著凋亡。此外,活/死细胞检测显示内皮中有许多死细胞,扫描电子显微镜分析表明角膜内皮细胞表面微绒毛部分缺失,细胞间连接广泛破坏。然而,Cosopt-S组角膜水肿轻微,角膜内皮损伤最小。
角膜内皮毒性的主要原因是多佐胺/噻吗洛尔固定组合滴眼液中的防腐剂,而非活性成分。因此,术后早期使用无防腐剂滴眼液似乎更安全。